Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. Kurt Wolff is a prominent German family-owned company specializing in the development and marketing of pharmaceutical and cosmetic products, operating as part of the Dr. Wolff Group. The company's oral care division is globally recognized for its innovation in biomimetic hydroxyapatite (BioHAP), which serves as a fluoride-free alternative for enamel remineralization and caries prevention in brands like Karex and Bioniq. Beyond oral health, the company manages a diverse portfolio of research-driven brands including Alpecin for hair care and Linola for dermatology. Dr. Kurt Wolff emphasizes clinical validation and scientific research to bridge the gap between traditional pharmaceuticals and consumer cosmetics. The company maintains a strong international presence, distributing its specialized healthcare solutions across Europe, Asia, and North America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oral Care Dr. Kurt Wolff.